Thursday, November 12, 2026||
MultiKhabarMultiKhabar

Nvidia ‘preparing to oust’ Jensen Huang, allegation of second affair emerges

TH
The Age Australia
By Nick Bonyhady
Share:WhatsAppFacebookX (Twitter)Telegram
Nvidia ‘preparing to oust’ Jensen Huang, allegation of second affair emerges
Photo / Coverage: The Age AustraliaCredit: Nick Bonyhady
EXECUTIVE SUMMARY

The Wall Street Journal has reported Nvidia’s board is preparing to oust its CEO after he had two extramarital affairs, including one with a suspected Chinese spy.

Key Takeaways

  • Nvidia ‘preparing to oust’ Jensen Huang, allegation of second affair emerges.
  • The Wall Street Journal has reported Nvidia’s board is preparing to oust its CEO after he had two extramarital affairs, including one with a suspected Chinese spy.
  • The Wall Street Journal has reported Nvidia’s board is preparing to oust its CEO after he had two extramarital affairs, including one with a suspected Chinese spy.

The Wall Street Journal has reported Nvidia’s board is preparing to oust its CEO after he had two extramarital affairs, including one with a suspected Chinese spy.

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Age Australia

Visit Publisher Site →
OTHER MEDIA SOURCES COVERING THIS STORY
3 Publishers Reporting
Sydney Morning Herald
Nvidia ‘preparing to oust’ Jensen Huang, allegation of second affair emerges
The Globe and Mail - World
Nvidia board reportedly preparing to oust CEO Jensen Huang

Related News

🇦🇺 Australia
Miro clears TGA audit ahead of Crohn’s disease trial
World24m ago

Miro clears TGA audit ahead of Crohn’s disease trial

Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.

The Age Australia
Miro clears TGA audit ahead of Crohn’s disease trial
World24m ago

Miro clears TGA audit ahead of Crohn’s disease trial

Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.

Sydney Morning Herald
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play